About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT00801879

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

Staphylococcus aureus is a bacteria that causes serious, often life threatening infections including pneumonia, wound, and bloodstream infections. Persons with AIDS are at high risk for S. aureus infe...

Lead sponsor: Columbia University•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Columbia University

Collaborators

GlaxoSmithKline
National Institute of Allergy and Infectious Diseases (NIAID)

This was a randomized double-blinded placebo controlled trial. Subjects were treated with intranasal mupirocin or placebo on a monthly basis and tested for nasal colonization a month after each treatment. This was performed up to 8 months.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Resident at Project Samaritan Inc. (PSI)

Exclusion Criteria

•Past hypersensitivity to mupirocin or glycerol
•Pregnancy
•Lactation
•Expected discharge from PSI in the following month
•Treatment with intranasal mupirocin within the preceding two months

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

RECRUITINGPhase 4

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

NCT06650501 · Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, and more

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047 · HIV, HIV Infections

RECRUITINGPhase 1/2

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

NCT06749457 · Staphylococcus Aureus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 29, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment100

Start dateSep 2003

Last updatedOct 29, 2014

Condition

Staphylococcus Aureus HIV Infections

Locations shown

Columbia University

New York, New York

Project Samaritan Inc.

The Bronx, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 29, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions